ArticleThe oncologist2024
Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation.
Casey Moore et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it